LEADER 02393nam  2200637Ia 450 
001 9910454905103321
005 20200520144314.0
010   $a1-282-27265-9
010   $a9786612272653
010   $a0-309-13125-1
035   $a(CKB)1000000000789198
035   $a(OCoLC)427878159
035   $a(CaPaEBR)ebrary10327027
035   $a(SSID)ssj0000096382
035   $a(PQKBManifestationID)11121580
035   $a(PQKBTitleCode)TC0000096382
035   $a(PQKBWorkID)10076939
035   $a(PQKB)10857566
035   $a(MiAaPQ)EBC3378514
035   $a(Au-PeEL)EBL3378514
035   $a(CaPaEBR)ebr10327027
035   $a(CaONFJC)MIL227265
035   $a(OCoLC)923280588
035   $a(EXLCZ)991000000000789198
100   $a20090819d2009      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aAccelerating the development of biomarkers for drug safety$b[electronic resource] $eworkshop summary /$fSteve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2009
215   $a1 online resource (99 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-13124-3 
320   $aIncludes bibliographical references (p. 55-57).
606   $aBiochemical markers$vCongresses
606   $aDrugs$xSafety measures$vCongresses
606   $aDrugs$xTesting$vCongresses
608   $aElectronic books.
615  0$aBiochemical markers
615  0$aDrugs$xSafety measures
615  0$aDrugs$xTesting
676   $a616.075
701   $aGiffin$b Robert B$0906709
701   $aOlson$b Steve$f1956-$0488724
701   $aRobinson$b Sally$0620917
712 02$aNational Research Council (U.S.).$bPlanning Committee for Assessing and Accelerating the Development of Biomarkers for Drug Safety : a Workshop.
712 12$aAssessing and Accelerating the Development of Biomarkers for Drug Safety. Workshop$f(2008 :$eWashington, D.C.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910454905103321
996   $aAccelerating the development of biomarkers for drug safety$92027862
997   $aUNINA